Records 1 - 11
| Gene polymorphisms of cyclin-dependent kinase inhibitor and matrix metalloproteinase-9 in Sudanese patients with esophageal squamous cell carcinoma.
Molecular genetics & genomic medicine 2022 Oct e2074.
Eltayeb Majdolin Mohammed, Ali Mohamed M, Omar Saeed M, Mohamed Nouh Saad, Adam Ishag, Hamdan Hamdan
| Association of Smoking and XPG, CYP1A1, OGG1, ERCC5, ERCC1, MMP2, and MMP9 Gene Polymorphisms with the early detection and occurrence of Laryngeal Squamous Carcinoma.
Journal of Cancer 2018 9 (6): 968-977.
Zhu Yi, Guo Luo, Wang ShengZi, Yu Qun, Lu JianXio
| MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis.
Genetic testing and molecular biomarkers 2015 Aug .
Tao Liu, Li Zuo, Lin Li, Lei Yin, Hongyuan Yu, Hongwei Jing, Yang Liu, Chuize Ko
| Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.
Genetics and molecular research : GMR 2015 14 (2): 4616-24.
Zhang L, Xi R-X, Zhang X
| Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk.
Medical science monitor : international medical journal of experimental and clinical research 2014 20 2269-74.
Guan Xuan, Wang Xiang, Luo Hao, Wu Jing, Zhang Xiao, Wu J
| Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.
Journal of cancer research and clinical oncology 2013 Sep 139 (9): 1433-47.
Li Xiaoying, Qu Lianxi, Zhong Yu, Zhao Yingjie, Chen Hongyan, Daru
| A miR-151 binding site polymorphism in the 3'-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma.
Biochemical and biophysical research communications 2013 Mar 432 (4): 660-5.
Liu Ying, Cai Hongbing, Liu Jie, Fan Haoning, Wang Zhiyuan, Wang Qirui, Shao Meng, Sun Xuegang, Diao Jianxin, Liu Yuanliang, Shi Yusheng, Fan Q
| Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Dec 17 (12): 3551-7.
Nan Hongmei, Niu Tianhua, Hunter David J, Han Jia
| MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.
Clinical genetics 2008 Mar 73 (3): 273-8.
Wu L M, Zhang F, Xie H Y, Xu X, Chen Q X, Yin S Y, Liu X C, Zhou L, Xu X B, Sun Y L, Zheng S
| Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
Human mutation 2007 Nov 28 (11): 1091-7.
Zhou Gangqiao, Zhai Yun, Cui Ying, Qiu Wei, Yang Hao, Zhang Xiumei, Dong Xiaojia, He Ying, Yao Kaitai, Zhang Hongxing, Peng Yong, Yuan Xiaoyan, Zhi Lianteng, Zhang Xiaoai, He Fuc
| Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population.
Cancer letters 2006 Sep 241 (1): 59-63.
Awakura Yasuo, Ito Noriyuki, Nakamura Eijiro, Takahashi Takeshi, Kotani Hirokazu, Mikami Yoshiki, Manabe Toshiyuki, Kamoto Toshiyuki, Habuchi Tomonori, Ogawa Osa